Krsnaa Diagnostics Optimistic as Rajasthan Ramp-Up Starts Q1 FY27

Krsnaa Diagnostics Limited — Q4 FY26 Earnings Call (Quarter & Year ended Mar 31, 2026)

1. Overall Tone of Management: Optimistic

• Management repeatedly emphasizes “confidence, clarity and large long-term vision for scale” and “highly optimistic about opportunities ahead for FY ’27.”
• They highlight strong FY26 delivery (~28% EBITDA margin, PAT > INR1,000m) while framing execution as “disciplined execution” and “on track” for working capital improvements.

2. Key Themes from Management Commentary

• PPP-led integrated platform as a moat: Integrated radiology + pathology, 24/7 operations, and PPP presence framed as “extremely difficult to replicate” once infrastructure is built.
• Long-term revenue visibility: Management cites ~INR6,000–INR7,000 crores over 5–7 years from existing + newly secured business.
• FY26 performance + scale-up simultaneously: Delivered FY26 revenues ~INR7,728m and EBITDA ~INR2,149m (~28%) while executing major expansions.
• Rajasthan ramp-up as the near-term swing factor: Rajasthan contribution expected to start from Q1 FY27, with installations largely completed by Q2.
• Working capital discipline improving: DSO reduced from 155 days (Q3) to 139 days (Q4); reiterated target to reach sub-120 days in FY27.
• Retail as a second engine: Retail is still ~8% of revenue but management expects it to scale to double digits and become a cash flow driver.
• Apulki Healthcare partnership narrative: Investment thesis validated; exclusive diagnostics rights for 30+ years in oncology/cardiology ecosystem.

3. Q&A Analysis

Theme A: Rajasthan ramp-up timing, revenue potential, and margin/cost impact

• Core questions:
• When will Rajasthan start contributing (H1 vs H2)?
• Revenue potential for FY27 and why earlier guidance changed (INR250–300 cr aspiration vs INR100–150 cr now).
• Upfront costs/capex and whether they will pressure margins.
• Management response:
• No Rajasthan contribution in Q4; expects contribution from Q1 FY27, installations mostly by Q2.
• Rajasthan revenue guidance: INR100–150 cr full-year (conservative ramp-up stance).
• Earlier higher numbers were framed as “aspiration… conservative approach” due to ramp-up variability.
• Margin impact: expects some Q1 pressure due to manpower onboarding (~5,000 people) but aims to maintain annualized EBITDA margins.
• Notable signals / evasiveness:
• Guidance is repeatedly calibrated downward (“conservative stance”) without fully reconciling the magnitude of prior expectations.
• Detailed depreciation/interest impact deferred to offline (see Theme F).

Theme B: PPP order pipeline / renewals / new wins

• Core questions:
• Status of remaining radiology PPP centers (Maharashtra) and when they complete.
• Whether there is a pipeline of new PPP orders in FY27.
• Quantum of projects up for renewal and likelihood of non-renewals.
• Management response:
• Radiology: ~10 MRIs going live in coming weeks; total under implementation 17 MRIs, with 10 in Q1/Q2 and 7 later.
• PPP renewals: “except for Tamil Nadu, there are not major contracts which are up for renewal during the year.”
• New orders: management says “a couple of PPP opportunities… in the works” and hopes to update in coming quarters; otherwise no clear pipeline disclosed.
• Notable signals:
• Analyst explicitly noted “no pipeline also”; management did not provide a concrete pipeline number—only “selective opportunities” and hope for updates.

Theme C: Like-for-like PPP growth and pricing mechanics

• Core questions:
• Like-to-like PPP growth adjusting for non-renewals/closures.
• Whether PPP pricing has escalation clauses; how pricing works.
• Management response:
• Like-to-like organic growth for continuing projects: ~13-odd% (quarter details to be shared offline).
• Pricing escalation: contractually embedded 2%–5% escalations, varying by tender (annual or alternate-year).
• Notable signals:
• Quarter-level like-to-like growth not provided on-call (offline).

Theme D: Receivables risk, delayed collections, and government-change risk

• Core questions:
• Amount of receivables delayed >6 months (HP/Karnataka).
• How management mitigates structural risk from government changes and whether receivables could suddenly become “risky.”
• Management response:
• HP and Karnataka collections have resumed; delays attributed to administrative/procedural factors (official transfers, system transitions like SNS SPARSH, budget approvals).
• Management claims “virtually 0 bad debt since inception” and says delays are “administrative in nature, not a credit risk issue.”
• Contractual leverage: they can suspend operations if payments are not done, and they’ve used this to get confirmations/payments.
• Notable signals / partial answers:
• Analyst asked for quantum of delayed receivables; management offered to share state-wise amounts offline.
• Government-change risk is addressed rhetorically (“governments come and go”), but the call does not quantify downside scenarios.

Theme E: Retail performance, touch points, margins, and longer-horizon aspiration

• Core questions:
• Retail QoQ flatness and whether margins (29–30%) are sustainable or one-off.
• Touch points allegedly declining for two quarters (analyst observation).
• Retail mix (B2C vs B2B) and marketing strategy.
• Longer-term retail contribution aspiration.
• Management response:
• Retail QoQ muted: framed as normal business lumpiness; expects growth in upcoming quarters.
• Margin: aims to maintain current EBITDA margin level; Q1 may see manpower deployment pressure.
• Touch points: management disputes the premise—says touch points are progressively expanding; revenue muted vs Q3.
• Longer horizon: retail contribution ~25%–30% of group revenue over 3–5 years.
• B2C/B2B: B2C prioritized; B2B described as accessibility support; specific B2B number reconciliation deferred offline.
• Notable signals:
• Management was defensive on touch-point trend and B2B mix, suggesting potential data interpretation gaps.

Theme F: RPL (retail pathology lab) / Apulki / RPL margins and accounting impacts

• Core questions:
• RPL EBITDA trajectory and whether FY27 margins improve YoY.
• Apulki accounting status and whether partnership monetized; exclusivity details.
• Depreciation/interest impact from Rajasthan capitalization.
• Management response:
• RPL: first year EBITDA negative due to manpower/logistics; expects positive EBITDA in FY27 and to reach consolidated EBITDA levels by end of FY27.
• Apulki: not an associate; partnership intact with exclusive diagnostics rights for 30+ years; hospitals ramp-up drives diagnostics demand.
• Rajasthan capitalization: capitalization from Q1, around INR200-odd crores; depreciation/interest quantified deferred to offline.
• Notable signals:
• Clear admission of negative EBITDA in RPL first year (but framed as expected ramp-up).

4. Guidance / Outlook

Explicit guidance (quantitative)

• Rajasthan revenue potential (full-year basis): INR100–150 crores (conservative ramp-up).
• Rajasthan ramp timing: contribution from Q1 FY27, installations mostly completed by Q2.
• Rajasthan capex / FY27 capitalization: total capital investment planned INR5,000m in FY27; Rajasthan + MRI + small projects breakdown: Rajasthan ~INR300+ cr, MRI ~INR150+ cr, balance small projects.
• Working capital / DSO: DSO improved to 139 days; target sub-120 days in FY27 “on track.”
• Retail contribution: expected to scale to double digits; longer horizon retail share ~25%–30% of group revenue (3–5 years).
• Retail margin: management aims to maintain EBITDA margins ~29–30% annually; Q1 may see pressure.
• PPP like-to-like organic growth: ~13-odd% for continuing projects (quarter details offline).
• RPL EBITDA: first year negative; expects positive EBITDA in FY27 and margin recovery by end FY27.
• Dividend: Board recommended INR2 per share (40% of face value).

Implicit signals (qualitative)

• Pipeline uncertainty: “a couple of PPP opportunities… in the works” but no concrete order wins disclosed.
• Conservative communication: repeated “calibrated” and “conservative stance” on guidance suggests management is managing execution/ramp-up variability risk.
• Margin protection priority: multiple statements that cost and revenue should move “hand-in-hand,” aiming to avoid structural margin damage.

5. Standout Statements (direct / high-signal)

• Long-term visibility: “nearly INR6,000 crores to INR7,000 crores over the next 5 to 7 years.”
• Rajasthan ramp conservatism: “we’d like to have a conservative approach” (re: INR100–150 cr vs earlier higher aspiration).
• Working capital discipline: “reduced our DSO from 155 days… to 139 days” and “sub 120 days… remains on track.”
• Receivables risk framing: “virtually 0 bad debt since inception” and delays are “administrative in nature, not a credit risk issue.”
• Retail margin stance: “working towards maintaining the current level of EBITDA margins… some impact in Q1… but on an annualized basis… maintain.”
• RPL admission: “In the first year, the EBITDA was negative… manpower… logistic costs.”
• Apulki exclusivity: “exclusive rights for all the diagnostics… for the next 30-plus years.”

6. Red Flags / Positive Signals

Red flags
– Guidance calibration / potential narrative drift: Rajasthan revenue guidance reduced to INR100–150 cr with “conservative approach,” after earlier higher aspirations (INR250–300 cr mentioned by an analyst).
– Pipeline opacity: repeated deferrals (“update offline,” “in the coming quarters”) and limited disclosure of new PPP wins.
– Receivables quantification deferred: asked for delayed >6 months amounts; management offered offline state-wise numbers.
– Data defensiveness in retail metrics: touch-point trend dispute and B2B mix reconciliation deferred offline.

Positive signals
– Strong profitability + scale simultaneously: FY26 EBITDA margin ~28% while executing expansions.
– Working capital improvement trend: DSO down 155 → 139 and explicit target sub-120.
– Contractual controls on collections: ability to suspend operations if payments stuck; management claims it has “borne fruit.”
– Clear FY27 investment plan: INR5,000m capex capitalization with stated components (Rajasthan + MRI + small projects).

7. Historical Comparison & Consistency Analysis (vs prior calls)

a. Change in Tone Over Time

• Current (Q4 FY26): Optimistic but more risk-managed (“conservative approach,” “calibrated guidance”).
• Prior (Q3 FY26, Feb 2026): Tone was strongly confident about ramp-up and “timing issue and not structural,” with emphasis on cash recovery and normalized ramp.
• Shift classification: More Cautious
• Evidence: more frequent hedging around ramp-up timing, guidance ranges, and margin maintenance; less concrete pipeline disclosure.

b. Tracking Past Commitments vs Outcomes

• Rajasthan ramp timing (earlier):
• Past (Q1 FY26 Aug 2025): Rajasthan ramp-up expected over 6–9 months, revenues from next financial year.
• Past (Q3 FY26 Feb 2026): “ferociously working… completed within Q4… slippages in Q1.”
• Current (Q4 FY26): “no contribution in this quarter… Rajasthan contribution coming in from Q1 FY27… installations completed majorly by Q1, some into Q2.”
• Assessment: ⏳ Delayed / extended ramp (from “within Q4” to “Q1/Q2 FY27” contribution).
• Receivables target (100 days):
• Past (Q2 FY26 Nov 2025): Aim to bring receivables to ~100 days by year end.
• Current: DSO at 139 days, guiding to sub-120 days in FY27 (not 100).
• Assessment: ⏳ Delayed (100-day target not achieved; revised to 120-day).
• Retail breakeven timing:
• Past (Nov 2025): Retail breakeven “by end of FY ’26” and contribution scaling.
• Current: Retail still ~8% of revenue; margin pressure expected in Q1 due to manpower; no explicit retail breakeven claim for FY27 on-call.
• Assessment: ⏳ Not clearly delivered / not re-affirmed.

c. Narrative Shifts

• From “growth visibility” to “conservative guidance”:
• Earlier calls emphasized strong ramp-up certainty (Rajasthan completion within Q4; higher revenue potential).
• Current call repeatedly frames guidance as realistic/conservative due to ramp-up variability.
• Receivables risk narrative becomes more explicit:
• Earlier: timing/system transitions; now more detailed discussion of government transfers, SNS SPARSH, and operational suspension mechanics.
• Pipeline discussion remains muted:
• Earlier: “tenders in pipeline” with expectation of updates.
• Current: “a couple of PPP opportunities… in the works” but no quantified pipeline.

d. Consistency & Credibility Signals

• Medium credibility
• Strength: consistent claims of 0 bad debt, working capital improvement, and margin protection intent.
• Weakness: repeated deferrals (offline numbers) and revised targets (100-day receivables → 120-day; Rajasthan revenue range reduced).
• No clear acknowledgment of missed targets beyond “conservative stance” and “timing/ramp-up variability.”

e. Evolution of Key Themes

• Demand/volumes: Still framed as resilient; however, Q4 shows Rajasthan not contributing yet, and retail revenue QoQ muted.
• Margins: Management consistently targets maintaining EBITDA margins; admits RPL first-year negative EBITDA but expects recovery in FY27.
• Expansion: Capex remains high and planned; execution timing is the main variable.
• Receivables: Theme evolves from “recovering dues” to “DSO improvement with administrative delays and suspension levers.”

f. Additional Insights (Cross-Period Intelligence)

• A pattern of “timing issues” persists, but the magnitude of timing slippage (Rajasthan contribution and receivables targets) suggests execution variability is becoming a recurring factor rather than a one-off.
• Management’s increasing reliance on offline follow-ups for key risk metrics (delayed receivables quantum, quarter like-to-like growth, depreciation/interest impact) reduces transparency on near-term downside.